The Cancer Center Isolation Facility (CCIF) is a 30,000 square foot, stand-alone building located in the heart of the Duke biomedical campus and dedicated to cancer research. Its physical plant supports work with hazardous materials at biosafety level 2 or 3, recombinant DNA, chemotherapeutics, as well as the maintenance of immunosuppressed and specific pathogen free rodents. Immunocompromised mice (outbred athymic nude mice and inbred Nod SCID gamma (NSG) mice) are bred within CCIF and are available to all investigators at Duke who have an approved IACUC animal protocol. The CCIF also maintains numerous xenograft lines derived from both pediatric and adult primary and metastatic tumors, including various brain tumors, sarcomas, melanomas, and breast cancers. CCIF personnel advise or suggest mentors to DCI investigators who require assistance with breeding services, veterinary or diagnostic services, animal and experimental protocol development, inoculation or testing of cell lines, preferable location of such inoculations, and a large variety of other information pertinent to performing safe and efficient research in the investigation of cancer biology. The 33 current users of CCIF are all DCI members and the CCIF contributed to 334 DCI publications during the funding period. Users represented eight of the nine CCSG-recognized Research Programs: Neuro-Oncology, Cancer Genetics and Genomics, Developmental Therapeutics, Hematologic Malignancies and Cellular Therapies, Tumor Biology, Women's Cancer, Radiation Oncology and Imaging, and Solid Tumor Therapeutics. CCIF also supports the CCSG-supported Optical Molecular Imaging and Analysis Shared Resource. CCIF contains facilities for the conduct of efficacy and toxicity studies that meet Good Laboratory Practice (GLP) regulations as required by the Food and Drug Administration to obtain Investigational New Drug permits. In the past 5 years, upgrades to equipment in the CCIF have occurred through significant investments by the Duke School of Medicine. The immediate and long-term objectives of the CCIF Shared Resource are to continue to provide high-quality barrier facility services, improve and upgrade services when possible, and to provide key expertise and services, including low-cost, high quality animals, to DCI members studying cancer biology and developing new agents for treating or diagnosing human cancers.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Career Development (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
United States
Zip Code
Duan, Bensong; Hu, Jiangfeng; Liu, Hongliang et al. (2018) Genetic variants in the platelet-derived growth factor subunit B gene associated with pancreatic cancer risk. Int J Cancer 142:1322-1331
Wu, Mengxi; Huang, Po-Hsun; Zhang, Rui et al. (2018) Circulating Tumor Cell Phenotyping via High-Throughput Acoustic Separation. Small 14:e1801131
Vlahovic, Gordana; Meadows, Kellen L; Hatch, Ace J et al. (2018) A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer. Oncologist 23:782-790
Xu, Yinghui; Liu, Hongliang; Liu, Shun et al. (2018) Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. Int J Cancer 143:2400-2408
Feng, Yun; Wang, Yanru; Liu, Hongliang et al. (2018) Novel genetic variants in the P38MAPK pathway gene ZAK and susceptibility to lung cancer. Mol Carcinog 57:216-224
Naqvi, Ibtehaj; Gunaratne, Ruwan; McDade, Jessica E et al. (2018) Polymer-Mediated Inhibition of Pro-invasive Nucleic Acid DAMPs and Microvesicles Limits Pancreatic Cancer Metastasis. Mol Ther 26:1020-1031
Wen, Juyi; Liu, Hongliang; Wang, Lili et al. (2018) Potentially Functional Variants of ATG16L2 Predict Radiation Pneumonitis and Outcomes in Patients with Non-Small Cell Lung Cancer after Definitive Radiotherapy. J Thorac Oncol 13:660-675
Li, Bo; Wang, Yanru; Xu, Yinghui et al. (2018) Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival. Int J Cancer 142:2303-2312
Gearhart-Serna, Larisa M; Jayasundara, Nishad; Tacam Jr, Moises et al. (2018) Assessing Cancer Risk Associated with Aquatic Polycyclic Aromatic Hydrocarbon Pollution Reveals Dietary Routes of Exposure and Vulnerable Populations. J Environ Public Health 2018:5610462
Bakthavatsalam, Subha; Sleeper, Mark L; Dharani, Azim et al. (2018) Leveraging ?-Glutamyl Transferase To Direct Cytotoxicity of Copper Dithiocarbamates against Prostate Cancer Cells. Angew Chem Int Ed Engl 57:12780-12784

Showing the most recent 10 out of 513 publications